FDA approves Vitrakvi for cancers with certain genetic trait
(HealthDay)—Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers
Read more
(HealthDay)—Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers
Read moreThere are many attributes that maketh the man (and the woman) but a majority of mums want their kids to be
Read more